Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Abel Sánchez-Aguilera"'
Autor:
Joan Isern, Beatriz Martín-Antonio, Roshanak Ghazanfari, Ana M. Martín, Juan A. López, Raquel del Toro, Abel Sánchez-Aguilera, Lorena Arranz, Daniel Martín-Pérez, María Suárez-Lledó, Pedro Marín, Melissa Van Pel, Willem E. Fibbe, Jesús Vázquez, Stefan Scheding, Álvaro Urbano-Ispizúa, Simón Méndez-Ferrer
Publikováno v:
Cell Reports, Vol 3, Iss 5, Pp 1714-1724 (2013)
Strategies for expanding hematopoietic stem cells (HSCs) include coculture with cells that recapitulate their natural microenvironment, such as bone marrow stromal stem/progenitor cells (BMSCs). Plastic-adherent BMSCs may be insufficient to preserve
Externí odkaz:
https://doaj.org/article/ad21aadd3f874fca80991a37cbdb96eb
Autor:
Lorraine Tracey, Mohit Aggarwal, Mónica García-Cosio, Raquel Villuendas, Patrocinio Algara, Margarita Sánchez-Beato, Abel Sánchez-Aguilera, Juan F. García, Antonia Rodríguez, Francisca I. Camacho, Nerea Martínez, Elena Ruiz-Ballesteros, Manuela Mollejo, Miguel Á. Piris
Publikováno v:
Haematologica, Vol 93, Iss 8 (2008)
Background Immunoglobulin gene somatic hypermutation is a biologically relevant and clinically useful prognostic factor in different types of low-grade B-cell lymphomas, including chronic lymphocytic leukemia, mantle cell lymphoma and splenic margina
Externí odkaz:
https://doaj.org/article/fcccffdc753e4357b8d77d9b220d7d24
Autor:
Juan F. García, Miguel A. Piris, Manolo M. Morente, José F. Tomas, Pedro Sánchez-Godoy, Angel Castaño, Eulogio Conde, Francisco Mazorra, Miguel Mendez, Maria J. Mestre, Cesar Morante, Manuel F. Fresno, Carmen Bellas, Concepción Poderos, Joaquín González-Carrero, Rafael Martinez, Carmen Martin, Carlos Montalbán, Abel Sánchez-Aguilera, Beatriz Sánchez-Espiridión
Purpose: Despite major advances in the treatment of classic Hodgkin's lymphoma (cHL), ∼30% of patients in advanced stages may eventually die as result of the disease, and current methods to predict prognosis are rather unreliable. Thus, the applica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e7ed9fe8b284537352f95352dd1eb6a
https://doi.org/10.1158/1078-0432.c.6517338
https://doi.org/10.1158/1078-0432.c.6517338
Autor:
Juan F. García, Miguel A. Piris, Manolo M. Morente, José F. Tomas, Pedro Sánchez-Godoy, Angel Castaño, Eulogio Conde, Francisco Mazorra, Miguel Mendez, Maria J. Mestre, Cesar Morante, Manuel F. Fresno, Carmen Bellas, Concepción Poderos, Joaquín González-Carrero, Rafael Martinez, Carmen Martin, Carlos Montalbán, Abel Sánchez-Aguilera, Beatriz Sánchez-Espiridión
Supplementary Data from A TaqMan Low-Density Array to Predict Outcome in Advanced Hodgkin's Lymphoma Using Paraffin-Embedded Samples
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ff2ba2d06b26de88613013f98e5776
https://doi.org/10.1158/1078-0432.22439955.v1
https://doi.org/10.1158/1078-0432.22439955.v1
Autor:
José L. Rodríguez-Peralto, Miguel A. Piris, Maria J. Artiga, Abel Sánchez-Aguilera, Raquel Pajares, Lydia Sánchez, Ana I. Sáez-Castillo, Salvio Serrano, Juan Linares, Marina Pollán, José Palacios, Beatriz Pérez-Gómez, Pablo Ortiz, Lorraine Tracey, Soledad R. Alonso
Supplementary Data from A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2919d546d691a87b193e68394ae19476
https://doi.org/10.1158/0008-5472.22366011.v1
https://doi.org/10.1158/0008-5472.22366011.v1
Autor:
José L. Rodríguez-Peralto, Miguel A. Piris, Maria J. Artiga, Abel Sánchez-Aguilera, Raquel Pajares, Lydia Sánchez, Ana I. Sáez-Castillo, Salvio Serrano, Juan Linares, Marina Pollán, José Palacios, Beatriz Pérez-Gómez, Pablo Ortiz, Lorraine Tracey, Soledad R. Alonso
Metastatic disease is the primary cause of death in cutaneous malignant melanoma (CMM) patients. To understand the mechanisms of CMM metastasis and identify potential predictive markers, we analyzed gene-expression profiles of 34 vertical growth phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aabdac987aaa89b619579ff0b862dfd
https://doi.org/10.1158/0008-5472.c.6494949.v1
https://doi.org/10.1158/0008-5472.c.6494949.v1
Autor:
Miguel A. Piris, Cesar Morante, Joaquín González-Carrero, Manolo M. Morente, Maria J Mestre, Carlos Montalbán, Angel Castaño, Beatriz Sanchez-Espiridion, Carmen Martin, Miguel Méndez, Juan F. García, Carmen Bellas, Eulogio Conde, Pedro Sánchez-Godoy, Concepción Poderos, Rafael Martínez, Manuel F. Fresno, Francisco Mazorra, Jose Francisco Tomas, Abel Sánchez-Aguilera
Publikováno v:
Clinical Cancer Research. 15:1367-1375
Purpose: Despite major advances in the treatment of classic Hodgkin's lymphoma (cHL), ∼30% of patients in advanced stages may eventually die as result of the disease, and current methods to predict prognosis are rather unreliable. Thus, the applica
Autor:
José García-Laraña, Vicens Romagosa, Abel Sánchez-Aguilera, Juan F. García, Carmen Bellas, Mónica García-Cosío, Concepción Nicolás, Maria J Mestre, Lydia Sanchez-Verde, Miguel A. Piris, Alberto Fernández de Sevilla, Manuel M. Morente, Carlos Montalbán, Manuel F. Fresno, Pilar Sabin, Javier Menárguez, Mariano Provencio, Miguel Méndez, Paloma de la Cueva
Publikováno v:
Blood. 108:662-668
Around 20% to 30% of patients with Hodgkin lymphoma (HL) do not benefit from standard therapies and finally succumb to their disease. The factors that influence the outcome of HL have not been elucidated, underscoring the demand for the identificatio
Autor:
Francisca I. Camacho, Antonia Rodriguez, Abel Sánchez-Aguilera, Patrocinio Algara, Nerea Martinez, Elias Campo, Pedro Javier Gómez Martínez, Miguel A. Piris, Manuela Mollejo, Elena Ruiz-Ballesteros, Javier Menárguez, Marisol Mateo, Marina Pollán
Publikováno v:
Blood. 106:1831-1838
Splenic marginal zone lymphoma (SMZL) is a newly recognized lymphoma type whose precise molecular pathogenesis is still essentially unknown. This hampers differential diagnosis with other small B-cell malignancies. With the aim of characterizing this
Autor:
Carlos Montalbán, Abel Sánchez-Aguilera, Margarita Sánchez-Beato, Miguel A. Piris, Julio Delgado, Carmen San Martín, Manuel F. Fresno, Juan F. García, Francisca I. Camacho, Lydia Sánchez
Publikováno v:
Blood. 103:2351-2357
p18INK4c is a cyclin-dependent kinase (CDK) inhibitor that interferes with the Rb-kinase activity of CDK6/CDK4. Disruption of p18INK4c in mice impairs B-cell terminal differentiation and confers increased susceptibility to tumor development; however,